Study of NR2E1 and SNX3 Genes in Patients with MMEP
Author Information
Author(s): Kumar Ravinesh A, Everman David B, Morgan Chad T, Slavotinek Anne, Schwartz Charles E, Simpson Elizabeth M
Primary Institution: Centre for Molecular Medicine and Therapeutics, Child & Family Research Institute, University of British Columbia
Hypothesis
Mutations in the neighbouring gene NR2E1 may underlie MMEP and related phenotypes.
Conclusion
The study found no coding mutations in NR2E1 or SNX3 in patients with MMEP, but regulatory mutations may still play a role.
Supporting Evidence
- No coding mutations were detected in NR2E1 or SNX3 in the studied patients.
- A candidate regulatory mutation was identified in one patient but not in control subjects.
- The study involved sequencing multiple regions of the NR2E1 gene.
Takeaway
The researchers looked at five patients with a rare condition and didn't find the usual gene mutations, but they think there might be other changes that could still cause problems.
Methodology
Mutation screening was performed using sequencing on five patients and 250 control subjects.
Limitations
The study cannot exclude the possibility of regulatory mutations or deletions at the NR2E1 or SNX3 loci.
Participant Demographics
Five patients with MMEP or related phenotypes, including Caucasian, Hispanic, and African-American individuals.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website